Glenview Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265M | Buy |
|
|||||
|
2025
Q1 | $227M | Buy |
|
|||||
|
2024
Q4 | $186M | Hold |
|
|||||
|
2024
Q3 | $152M | Sell |
|
|||||
|
2024
Q2 | $149M | Buy |
|
|||||
|
2024
Q1 | $106M | Buy |
|
|||||
|
2023
Q4 | $16.8M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $100M | Sell |
|
|||||
|
2016
Q2 | $155M | Sell |
|
|||||
|
2016
Q1 | $299M | Sell |
|
|||||
|
2015
Q4 | $391M | Buy |
|
|||||
|
2015
Q3 | $236M | Buy |
|
|||||
|
2015
Q2 | $168M | Buy |
|